Search: onr:"swepub:oai:prod.swepub.kib.ki.se:144389396" >
An Open-label, Phas...
An Open-label, Phase 2 Study to Evaluate the Oral Combination of Ixazomib, Cyclophosphamide, and Dexamethasone (ICd) in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM)
- Article/chapterEnglish2017
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:prod.swepub.kib.ki.se:144389396
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:144389396URI
-
https://doi.org/10.1016/j.clml.2017.07.148DOI
Supplementary language notes
Part of subdatabase
Classification
-
Subject category:vet swepub-contenttype
-
Subject category:kon swepub-publicationtype
Added entries (persons, corporate bodies, meetings, titles ...)
-
Grosicki, S
(author)
-
Jedrzejczak, W
(author)
-
Nahi, HKarolinska Institutet
(author)
-
Gruber, A
(author)
-
Hansson, M
(author)
-
Byrne, C
(author)
-
Labotka, R
(author)
-
Teng, ZY
(author)
-
Yang, HY
(author)
-
Grzasko, N
(author)
-
Kumar, S
(author)
-
Karolinska Institutet
(creator_code:org_t)
Related titles
-
In:CLINICAL LYMPHOMA MYELOMA & LEUKEMIA: Elsevier BV17, s. S333-S3342152-2650
Internet link
Find in a library
To the university's database
- By the author/editor
-
Dimopoulos, M
-
Grosicki, S
-
Jedrzejczak, W
-
Nahi, H
-
Gruber, A
-
Hansson, M
-
show more...
-
Byrne, C
-
Labotka, R
-
Teng, ZY
-
Yang, HY
-
Grzasko, N
-
Kumar, S
-
show less...
- Articles in the publication
-
CLINICAL LYMPHOM ...
- By the university
-
Karolinska Institutet